左心室尾阻塞:目前的进展和剩余的挑战
Mohamad Alkhouli1, Christopher R Ellis2, Matthew Daniels3
1Department of Cardiology, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.
JACC. Advances
|June 28, 2024
概括
左心房附属体封闭正在推进,但挑战仍然存在. 关键问题包括有限的随机数据,设备周边泄漏,与设备相关的血栓以及程序优化需求.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 干预程序 干预程序
背景情况:
- 左心房尾阻塞 (LAAO) 是一个不断增长的领域,用于预防心房动中风.
- 当前的挑战阻碍了广泛采用和最佳的患者结果.
研究的目的:
- 提供对LAAO的当代概述.
- 专注于该领域四个关键的剩余挑战.
主要方法:
- 审查当前的文献和临床数据.
- 分析影响LAAO有效性和安全性的关键问题.
主要成果:
- 有限的随机对照试验数据存在于LAAO的疗效.
- 周围设备泄漏和与设备相关的血栓仍然是一个重大问题.
- 程序技术需要不断改进以获得最佳结果.
结论:
- 应对这些挑战对于推动LAAO发展至关重要.
- 需要进一步的研究和技术改进,以最大限度地提高LAAO的利益.
相关概念视频
Chambers of the Heart
10.0K
The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...
Deoxygenated blood from the body is received in the right...
10.0K
Cardiac Catheterization III: Left Heart Catheterization
1.3K
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Pericarditis III: Medical Management
595
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
595
Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762


